This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1995-1996.
Company Filing History:
Years Active: 1995-1996
Title: Mark Krevolin: Innovator in Enzyme Technology
Introduction
Mark Krevolin is a notable inventor based in Pinole, California. He has made significant contributions to the field of enzyme technology, particularly through his innovative work on beta-galactosidase fragments. With a total of 2 patents, Krevolin's inventions have the potential to enhance various biochemical applications.
Latest Patents
Krevolin's latest patents include "Muteins of .beta.-galactosidase fragments having increased activity" and "Oxidation-resistant muteins of .beta.-galactosidase fragments." The first patent describes muteins of enzyme acceptor polypeptide fragments of beta-galactosidase that exhibit substantially increased kinetic complementation activity without significant loss in stability. This invention highlights preferred substitutions at specific amino acid positions to optimize enzyme performance. The second patent focuses on a mutein of an enzyme acceptor polypeptide fragment of beta-galactosidase that is resistant to oxidation, providing methods for producing the novel muteins and their applications in immunoassays.
Career Highlights
Mark Krevolin is currently employed at Boehringer Mannheim GmbH, where he continues to advance his research in enzyme technology. His work has garnered attention for its practical applications in various scientific fields.
Collaborations
Krevolin has collaborated with notable coworkers, including David J Ledden and Sophie J Boguslawski. Their combined expertise contributes to the innovative environment at Boehringer Mannheim GmbH.
Conclusion
Mark Krevolin's contributions to enzyme technology through his patents and collaborations demonstrate his commitment to advancing scientific knowledge and practical applications. His work continues to influence the field and pave the way for future innovations.